Sanofi Extends Genzyme Bid As Talks Continue

24.01.2011 - French drugmaker Sanofi-Aventis extended its snubbed $18.5 billion tender offer for U.S. biotech Genzyme for a second time as the companies continue behind-the-scenes talks to...